Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?-Reference-Cited by-同舟云学术

Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

Published:2013-10-25 Issue:1 Volume:68 Page:60-82
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Citrome L.¹

Affiliation:

1. New York Medical College; Valhalla NY USA

Publisher

Hindawi Limited

Subject

General Medicine

Reference47 articles.

1. Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder;Mørk;J Pharmacol Exp Ther,2012

2. Takeda and Lundbeck announce FDA approval of Brintellix ™ (vortioxetine) for treatment of adults with major depressive disorder 2013 http://www.takeda.com/news/files/20131001_en.pdf

3. Takeda Pharmaceuticals America, Inc. BRINTELLIX (vortioxetine) tablets, for oral use 2013 http://general.takedapharm.com/content/file/pi.pdf?applicationcode=396066C6-E50F-4113-ABAD-54FE9525BF7E&filetypecode=BRINTELLIXPI

4. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?;Citrome;Int J Clin Pract,2012

5. Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?;Citrome;Int J Clin Pract,2012

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics;Cell Host & Microbe;2024-06

2. Trazodone once-a-day: A formula for addressing challenges in antidepressant safety and tolerability;Neuroscience Applied;2023

3. Weight-centric treatment of depression and chronic pain;Obesity Pillars;2022-09

4. Cutting the First Turf to Heal Post-SSRI Sexual Dysfunction: A Male Retrospective Cohort Study;Medicines;2022-09-01

5. Vortioxetine - pharmacological properties and use in mood disorders. The current state of knowledge.;Psychiatria Polska;2022-08-19